Blue Jet Healthcare Ltd vs Gujarat Themis Biosyn Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Blue Jet Healthcare Ltd is ₹ 421.55 as of 18 May 15:30 . The P/E Ratio of Blue Jet Healthcare Ltd is 0 as of March 2021 .The P/E Ratio of Gujarat Themis Biosyn Ltd is 0 as of March 2021 . The Market Cap of Blue Jet Healthcare Ltd is ₹ 0 crore as of March 2021 .The Market Cap of Gujarat Themis Biosyn Ltd is ₹ 0 crore as of March 2021 . The revenue of Blue Jet Healthcare Ltd for the Dec '25 is ₹ 205.62 crore as compare to the Sep '25 revenue of ₹ 189.75 crore. This represent the growth of 8.36% The revenue of Gujarat Themis Biosyn Ltd for the Dec '25 is ₹ 43.78 crore as compare to the Sep '25 revenue of ₹ 43.17 crore. This represent the growth of 1.41% The ebitda of Blue Jet Healthcare Ltd for the Dec '25 is ₹ 60.1 crore as compare to the Sep '25 ebitda of ₹ 79.22 crore. This represent the decline of -24.14% The ebitda of Gujarat Themis Biosyn Ltd for the Dec '25 is ₹ 21.72 crore as compare to the Sep '25 ebitda of ₹ 21.76 crore. This represent the decline of -0.18% The net profit of Blue Jet Healthcare Ltd changed from ₹ 37.78 crore to ₹ 40.17 crore over 7 quarters. This represents a CAGR of 3.57% The net profit of Gujarat Themis Biosyn Ltd changed from ₹ 13.24 crore to ₹ 12.46 crore over 7 quarters. This represents a CAGR of -3.41% The Dividend Payout of Blue Jet Healthcare Ltd changed from 10.59 % on March 2024 to 6.82 % on March 2025 . This represents a CAGR of -19.75% over 2 yearsThe Dividend Payout of Gujarat Themis Biosyn Ltd changed from 36.62 % on March 2022 to 14.97 % on March 2025 . This represents a CAGR of -20.04% over 4 years .

About Blue Jet Healthcare Ltd

Blue Jet Healthcare Limited was originally incorporated as Jet Chemicals Private Limited,' at Mumbai, dated December 7, 1968.
The Company name was changed to Blue Jet Healthcare Private Limited', and a fresh Certificate of Incorporation dated December 30, 2020, was issued by the Registrar of Companies, Mumbai.
Subsequently, the status got converted into a Limited Company and its name was changed to Blue Jet Healthcare Limited' on May 18, 2022. The Company is a global, science-led, pharmaceutical company evolved as strategic partner for Collaboration, Development & Manufacturing of Advance Pharmaceutical Intermediates and API. It operate into 3 product categories, contrast media intermediates, high- intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs).

About Gujarat Themis Biosyn Ltd

Promoted byJayshree D Patel, Gujarat Themis Biosyn Limited (GTBL) was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985.
It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007. Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990.

FAQs for the comparison of Blue Jet Healthcare Ltd and Gujarat Themis Biosyn Ltd

Which company has a larger market capitalization, Blue Jet Healthcare Ltd or Gujarat Themis Biosyn Ltd?

Market cap of Blue Jet Healthcare Ltd is 7,458 Cr while Market cap of Gujarat Themis Biosyn Ltd is 3,788 Cr

What are the key factors driving the stock performance of Blue Jet Healthcare Ltd and Gujarat Themis Biosyn Ltd?

The stock performance of Blue Jet Healthcare Ltd and Gujarat Themis Biosyn Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Blue Jet Healthcare Ltd and Gujarat Themis Biosyn Ltd?

As of May 18, 2026, the Blue Jet Healthcare Ltd stock price is INR ₹429.95. On the other hand, Gujarat Themis Biosyn Ltd stock price is INR ₹347.65.

How do dividend payouts of Blue Jet Healthcare Ltd and Gujarat Themis Biosyn Ltd compare?

To compare the dividend payouts of Blue Jet Healthcare Ltd and Gujarat Themis Biosyn Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.